Tokyo Tape
Sign in
← Chiome Bioscience

Annual report

4583.TEDINET S100QGF6
Period2022-01-01 → 2022-12-31
Filed2023-03-28
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Key figures · 76
MetricValuePeriodScopeSource row
Revenue¥631m2022-01-01 → 2022-12-31StandaloneNet sales
Revenue¥713m2021-01-01 → 2021-12-31StandaloneNet sales
Revenue¥481m2020-01-01 → 2020-12-31dStandaloneNet sales (5-year summary)
Revenue¥448m2019-01-01 → 2019-12-31dStandaloneNet sales (5-year summary)
Revenue¥213m2018-01-01 → 2018-12-31dStandaloneNet sales (5-year summary)
Operating income−¥1.3bn2022-01-01 → 2022-12-31StandaloneOperating income
Operating income−¥1.3bn2021-01-01 → 2021-12-31StandaloneOperating income
Ordinary income−¥1.2bn2022-01-01 → 2022-12-31StandaloneOrdinary income
Ordinary income−¥1.3bn2021-01-01 → 2021-12-31StandaloneOrdinary income
Ordinary income−¥1.3bn2020-01-01 → 2020-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥1.4bn2019-01-01 → 2019-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥1.5bn2018-01-01 → 2018-12-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax−¥1.2bn2022-01-01 → 2022-12-31StandaloneIncome before income taxes
Profit before tax−¥1.5bn2021-01-01 → 2021-12-31StandaloneIncome before income taxes
Net income−¥1.2bn2022-01-01 → 2022-12-31StandaloneProfit loss
Net income−¥1.5bn2021-01-01 → 2021-12-31StandaloneProfit loss
Net income−¥1.3bn2020-01-01 → 2020-12-31dStandaloneNet income loss (5-year summary)
Net income−¥1.4bn2019-01-01 → 2019-12-31dStandaloneNet income loss (5-year summary)
Net income−¥1.5bn2018-01-01 → 2018-12-31dStandaloneNet income loss (5-year summary)
Total assets¥2.2bnat 2022-12-31StandaloneAssets
Total assets¥2.3bnat 2021-12-31StandaloneAssets
Total assets¥3.5bnat 2020-12-31dStandaloneTotal assets (5-year summary)
Total assets¥2.8bnat 2019-12-31dStandaloneTotal assets (5-year summary)
Total assets¥2.8bnat 2018-12-31dStandaloneTotal assets (5-year summary)
Total liabilities¥425mat 2022-12-31StandaloneLiabilities
Total liabilities¥446mat 2021-12-31StandaloneLiabilities
Net assets / equity¥1.8bnat 2022-12-31StandaloneNet assets
Net assets / equity¥1.9bnat 2021-12-31StandaloneNet assets
Net assets / equity¥3.1bnat 2020-12-31dStandaloneNet assets
Net assets / equity¥2.6bnat 2019-12-31dStandaloneNet assets (5-year summary)
Net assets / equity¥2.7bnat 2018-12-31dStandaloneNet assets (5-year summary)
Cash and deposits¥1.7bnat 2022-12-31StandaloneCash and deposits
Cash and deposits¥1.8bnat 2021-12-31StandaloneCash and deposits
Cash & equivalents¥1.7bnat 2022-12-31StandaloneCash and cash equivalents
Cash & equivalents¥1.8bnat 2021-12-31StandaloneCash and cash equivalents
Cash & equivalents¥2.7bnat 2020-12-31dStandaloneCash and cash equivalents
Cash & equivalents¥2.1bnat 2019-12-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥2.3bnat 2018-12-31dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow−¥1.2bn2022-01-01 → 2022-12-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥1.1bn2021-01-01 → 2021-12-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥1.4bn2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥1.5bn2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥1.7bn2018-01-01 → 2018-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥35m2021-01-01 → 2021-12-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥4m2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥26m2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow¥1.1bn2022-01-01 → 2022-12-31StandaloneNet cash provided by used in financing activities
Financing cash flow¥271m2021-01-01 → 2021-12-31StandaloneNet cash provided by used in financing activities
Financing cash flow¥1.9bn2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥1.3bn2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow−¥10m2018-01-01 → 2018-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥-28.262022-01-01 → 2022-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-36.742021-01-01 → 2021-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-36.062020-01-01 → 2020-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-44.612019-01-01 → 2019-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-57.262018-01-01 → 2018-12-31dStandaloneBasic earnings loss per share (5-year summary)
Net assets per share¥36.7at 2022-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥45.55at 2021-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥77.99at 2020-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥78.1at 2019-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥98.89at 2018-12-31dStandaloneNet assets per share (5-year summary)
Equity ratio80.2%at 2022-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio79.4%at 2021-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio88.2%at 2020-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio92.6%at 2019-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio93.5%at 2018-12-31dStandaloneEquity to asset ratio (5-year summary)
Shares issued48,423,500at 2022-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued40,781,500at 2021-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued39,505,200at 2020-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued33,283,500at 2019-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued26,781,500at 2018-12-31dStandaloneTotal number of issued shares (5-year summary)
Employees49at 2022-12-31StandaloneNumber of employees
Employees49at 2021-12-31StandaloneNumber of employees
Employees42at 2020-12-31dStandaloneNumber of employees
Employees38at 2019-12-31dStandaloneNumber of employees
Employees37at 2018-12-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 21
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment assetsat 2022-12-31¥2.2bn
Reconciling Itemsreconcilingsegment profit2022-01-01 → 2022-12-31−¥472m
Drug Discovery And Developmentreportable segmentsegment profit2022-01-01 → 2022-12-31−¥1.1bn
Drug Discovery Supportreportable segmentrevenue2022-01-01 → 2022-12-31¥631m
Drug Discovery Supportreportable segmentrevenue external2022-01-01 → 2022-12-31¥631m
Drug Discovery Supportreportable segmentsegment profit2022-01-01 → 2022-12-31¥349m
—segment totalemployeesat 2022-12-3139 pure
Total Of Reportable Segments And Otherssegment totalrevenue2022-01-01 → 2022-12-31¥631m
Total Of Reportable Segments And Otherssegment totalrevenue external2022-01-01 → 2022-12-31¥631m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-01-01 → 2022-12-31−¥787m
Reconciling Itemsreconcilingsegment assetsat 2021-12-31¥2.3bn
Reconciling Itemsreconcilingsegment profit2021-01-01 → 2021-12-31−¥445m
Drug Discovery And Developmentreportable segmentrevenue2021-01-01 → 2021-12-31¥103m
Drug Discovery And Developmentreportable segmentrevenue external2021-01-01 → 2021-12-31¥103m
Drug Discovery And Developmentreportable segmentsegment profit2021-01-01 → 2021-12-31−¥1.2bn
Drug Discovery Supportreportable segmentrevenue2021-01-01 → 2021-12-31¥610m
Drug Discovery Supportreportable segmentrevenue external2021-01-01 → 2021-12-31¥610m
Drug Discovery Supportreportable segmentsegment profit2021-01-01 → 2021-12-31¥320m
Total Of Reportable Segments And Otherssegment totalrevenue2021-01-01 → 2021-12-31¥713m
Total Of Reportable Segments And Otherssegment totalrevenue external2021-01-01 → 2021-12-31¥713m
Total Of Reportable Segments And Otherssegment totalsegment profit2021-01-01 → 2021-12-31−¥890m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 834
ItemContextValueUnit
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember48423500
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant48423500
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant48423500
Number of shares constituting one unitCurrentYearInstant_OrdinaryShareMember100
Number of shareholders national and local governmentsCurrentYearInstant_OrdinaryShareMember－
Number of shareholders financial institutionsCurrentYearInstant_OrdinaryShareMember2
Number of shareholders financial service providersCurrentYearInstant_OrdinaryShareMember27
Number of shareholders other corporationsCurrentYearInstant_OrdinaryShareMember95
Number of shareholders foreign investors other than individualsCurrentYearInstant_OrdinaryShareMember17
Number of shareholders foreign individual investorsCurrentYearInstant_OrdinaryShareMember73
Number of shareholders individuals and othersCurrentYearInstant_OrdinaryShareMember22181
Number of shareholders totalCurrentYearInstant_OrdinaryShareMember22395
Number of shares held number of units national and local governmentsCurrentYearInstant_OrdinaryShareMember－
Number of shares held number of units financial institutionsCurrentYearInstant_OrdinaryShareMember2797
Number of shares held number of units financial service providersCurrentYearInstant_OrdinaryShareMember56165
Number of shares held number of units other corporationsCurrentYearInstant_OrdinaryShareMember5948
Number of shares held number of units foreign investors other than individualsCurrentYearInstant_OrdinaryShareMember4075
Number of shares held number of units foreign individual investorsCurrentYearInstant_OrdinaryShareMember1093
Number of shares held number of units individuals and othersCurrentYearInstant_OrdinaryShareMember414048
Number of shares held number of units totalCurrentYearInstant_OrdinaryShareMember484126
Number of shares held shares less than one unitCurrentYearInstant_OrdinaryShareMember10900
Percentage of shareholdings national and local governmentsCurrentYearInstant_OrdinaryShareMember－
Percentage of shareholdings financial institutionsCurrentYearInstant_OrdinaryShareMember0.0058
Percentage of shareholdings financial service providersCurrentYearInstant_OrdinaryShareMember0.1160
Percentage of shareholdings other corporationsCurrentYearInstant_OrdinaryShareMember0.0123
Percentage of shareholdings foreigners other than individualsCurrentYearInstant_OrdinaryShareMember0.0084
Percentage of shareholdings foreign individualsCurrentYearInstant_OrdinaryShareMember0.0023
Percentage of shareholdings individuals and othersCurrentYearInstant_OrdinaryShareMember0.8552
Number of shares heldCurrentYearInstant_No1MajorShareholdersMember1604021
Shareholding ratioCurrentYearInstant_No1MajorShareholdersMember0.0331
Number of shares heldCurrentYearInstant_No2MajorShareholdersMember1477900
Shareholding ratioCurrentYearInstant_No2MajorShareholdersMember0.0305
Number of shares heldCurrentYearInstant_No3MajorShareholdersMember962700
Shareholding ratioCurrentYearInstant_No3MajorShareholdersMember0.0198
Number of shares heldCurrentYearInstant_No4MajorShareholdersMember842100
Shareholding ratioCurrentYearInstant_No4MajorShareholdersMember0.0173
Number of shares heldCurrentYearInstant_No5MajorShareholdersMember580000
Shareholding ratioCurrentYearInstant_No5MajorShareholdersMember0.0119
Number of shares heldCurrentYearInstant_No6MajorShareholdersMember500000
Shareholding ratioCurrentYearInstant_No6MajorShareholdersMember0.0103
Number of shares heldCurrentYearInstant_No7MajorShareholdersMember497000
Shareholding ratioCurrentYearInstant_No7MajorShareholdersMember0.0102
Number of shares heldCurrentYearInstant_No8MajorShareholdersMember360000
Shareholding ratioCurrentYearInstant_No8MajorShareholdersMember0.0074
Number of shares heldCurrentYearInstant_No9MajorShareholdersMember313551
Shareholding ratioCurrentYearInstant_No9MajorShareholdersMember0.0064
Number of shares heldCurrentYearInstant_No10MajorShareholdersMember282700
Shareholding ratioCurrentYearInstant_No10MajorShareholdersMember0.0058
Number of shares heldCurrentYearInstant7419972
Shareholding ratioCurrentYearInstant0.1532

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 13 of 13 passed
balance sheet identitynon_consolidated 2021-12-31pass
balance sheet identitynon_consolidated 2022-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2020-12-31pass
statement vs summary · net assetsnon_consolidated 2021-12-31pass
statement vs summary · net assetsnon_consolidated 2022-12-31pass
statement vs summary · operating cash flownon_consolidated 2021-01-01/2021-12-31pass
statement vs summary · operating cash flownon_consolidated 2022-01-01/2022-12-31pass
statement vs summary · revenuenon_consolidated 2021-01-01/2021-12-31pass
statement vs summary · revenuenon_consolidated 2022-01-01/2022-12-31pass
statement vs summary · total assetsnon_consolidated 2021-12-31pass
statement vs summary · total assetsnon_consolidated 2022-12-31pass